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Volume 57, Number 5S Abstracts 33SA than group B (thrombotic, 3.6% vs 1.5%; P ¼ .02; device
related, 5% vs 0.5%; P < .0001).
Conclusions: Indwelling retrievable IVC ﬁlters were
associated with signiﬁcantly higher complication rates
than permanent ﬁlters. Both thrombotic and device related
complications were more common with retrievable ﬁlters.
Long term use of retrievable ﬁlters should be avoided,
especially considering the younger population in whom
they are placed.
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Objectives: Describe and quantify the effects of perfo-
rator sclerotherapy on venous ulcers (CEAP 6) without
axial reﬂux
Methods: Retrospective analysis of ultrasound (US)-
guided perforator injections from 1/2010-11/2012 iden-
tiﬁed 73 venous ulcers in 62 patients. Patients had no axial
reﬂux. Perforating vein identiﬁcation and closure were
assessed with US. Reﬂuxing perforators near the ulcer
were injected with polidocanol foam created in a 4:1
mixture with air. 98.4% of patients had US follow-up per-
formed 2-6 weeks after injection. Ulcers were divided into
two groups: group 1 healed ulcer(s); group 2 either healed
and recurred/never healed. All patients were treated with
compression therapy. Demographics, comorbidities, treat-
ment details and outcomes were analyzed. P # .05 was
signiﬁcant.
Results: 32 patients had healed ulcers; 30 had at least 1
non-healed ulcer. Comparisons of patients with healed vs
non-healed ulcers were: age 60.2 vs 61.3 years; male gender
50% vs 60%; history of deep vein thrombosis (DVT) 31.3%
vs 33.3% (P ¼ NS for all). Of the 73 total ulcers, 43 ulcers
were healed (group 1); 30 ulcers recurred/never healed
(group 2) for a healing rate of 59.9%. Initial ulcer size was
3.44 cm2 vs 15.1 cm2 (P ¼ NS).
189 injections were performed with a 53.8% success-
ful closure rate per injection. Successful thrombosis
occurred in 68.8% of group 1 vs 37.8% of group 2 (P
< .001). Group 1 ulcers averaged 2.2 injections per ulcer
vs 2.9 in group 2 (P ¼ .16). 24.7% of ulcers healed with
a single perforator injection. Post procedure DVTs were
seen: 5.8% of injections (11/189); four in group 1; seven
in group 2 (P ¼ NS). No other injection complications
were seen. 88.1% of group 1 ulcers had perforator
closure at the end of follow-up vs 67.8% of group 2
ulcers (P ¼ .038).
Conclusions: Successful thrombosis of pathologic
perforators with compression therapy increases ulcer heal-
ing and was found to be the only predictor of ulcer closure.Perforator closure may require multiple injections and is
associated with low DVT rates.
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Objectives: Previous studies have combined anasto-
motic, catheter-induced, and IFAA to achieve adequate
numbers for analysis, and have recommended repair of
asymptomatic IFAA with diameters $2.5 cm and all symp-
tomatic IFAA. This study evaluates the contemporary
management of IFAA, using these criteria.
Methods: Patients with IFAA were evaluated using
a standardized, prospectively maintained database by
a research consortium.
Results: From 2002-2012 236 IFAA were identiﬁed in
182 patients (mean age, 72; M:F, 16:1) at eight institutions.
Nonoperative mean diameter was 2.8 6 .7 cm; operative
diameter was 3.3 6 1.5 cm. IFAA location was: CFA
(191), SFA (34), and PFA (11). Synchronous aneurysms
(mean ¼ 1.7/patient) occurred in the aorta (181), iliac
(126), popliteal (96), hypogastric (63), mesenteric (17)
arteries, and contralateral SFA (7) and PFA (2). 66% of
repaired aneurysms were asymptomatic; other indications
included: claudication (18%), local pain (8%), nerve
compression (3%), rupture (3%), acute thrombosis (1%),
embolus (1%), and rest pain (.5%). Acute complications
(rupture, thrombosis, embolus) were associated (P < .05)
with FAA diameter >4 cm and intraluminal thrombus, but
not location. Mean diameter of symptomatic aneurysms
was: rupture, 5.7 6 1.3 cm; thrombosis, 4 6 1.1 cm; and
embolus, 3.66 .1 cm. 174 IFAAwere repairedwith interpo-
sition or bypass graft; three underwent endovascular repair.
There were two perioperative deaths at 30 days (MI,
MSOF); operative complications included wound infection
(6%), seroma (3%), and bleeding (2%). No amputations
occurred up to 5 years in either the nonoperative or operative
groups. Survivalwas: 3months¼99% (138), 1 year¼92% (n
¼ 104), and 5 years ¼ 81% (20) in operated patients.
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that: 1. Acute complications did not occur in aneurysms
smaller than 3.5cm; repair criteria for asymptomatic FAA
should be changed to >3.5 cm 2. The presence of chronic
FAA thrombus should reduce the threshold for elective
repair. 3. Criteria for symptomatic FAA repair should
remain unchanged.
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Background: Transcatheter aortic valve replacement
(TAVR) has revolutionized treatments for patients with
severe symptomatic aortic valve stenosis. In 2011 FDA
approved TAVR for surgically inoperable patients, and in
2012 for surgical high risk patients. Currently randomized
trials are underway evaluating the efﬁcacy of TAVR for
surgical low risk patients. Similar to TEVAR, TAVR
requires navigation of 22-25Fr sheaths and catheters across
the aortoiliac segments and expose patients to the risks of
arterial injury, bleeding, and stroke. As vascular surgeons
we have participated in nearly 100 TAVR procedures, and
can attest to the importance of vascular surgeons involve-
ment in not only limiting patient risks, but also in expanding
the indications for patients with critical aortic stenosis and
no other treatment options, as well as in managing bailouts
following complications of these procedures.
Technical Description: This video presentation will
focus on the implications of appropriate access during
TAVR. Tips and tricks to the bailout procedures needed
during misplaced aortic valves that require retrieval, as
well as diagnosis and treatments for arterial injury during
trans-femoral and trans-apical TAVR.
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Objectives: Acute limb ischemia (ALI) in pediatric
patients is rare but may lead to limb loss and life-long
complications. The aim of this study was to review the
experience of a Canadian tertiary pediatric center with
the medical and operative management of ALI.
Methods: The charts of in-patients diagnosed with
acute upper or lower limb ischemia between 1999-2012
were reviewed. Patient demographics, arterial clot site and
etiology, intervention, anticoagulation type and duration,
and short and long-term complications were analyzed.
Results: 136 patients presented with signs of limb
ischemia (46% female, 34% younger than 30 days, 51%
between 1-12 months, and 15% between 1-18 years). 95%
involved the lower limbs. 85% of arterial clots were totally
occlusive. 92% were due to vessel catheterization, 5% were
idiopathic, and 2% were due to hereditary hypercoagulable
states. 96% were managed nonoperatively. Patients were
treated with a combination of thrombolysis, unfractionated
or low molecular-weight heparin, aspirin and/or warfarin
(duration, 1 day-13 years). All patients were followed postdi-
scharge at our institution or at their referring hospital (average,
3.5 years). 13%had complications related toALIor anticoagu-
lation (limb length or thigh circumference discrepancy, or
intracranial hemorrhage). 25 patients died of unrelated causes
(sepsis, multi-organ dysfunction, or cardiac failure).
Conclusions: In contrast with adults, ALI in children
can generally be managed nonoperatively with anticoagula-
tion, likely because of their greater ability to develop arte-
rial collaterals. Long-term follow-up by a multidisciplinary
team of pediatric and surgical specialists and allied health
professionals is integral to achieving a successful outcome.
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